Cargando…

A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice

Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7/8 agonist, 3M-052, induces long-lived humoral immunity in non-human primates and is currently being evaluated in human clinical trials. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Audrey, Scott, Madeleine K. D., Wimmers, Florian, Arunachalam, Prabhu S., Luo, Wei, Fox, Christopher B., Tomai, Mark, Khatri, Purvesh, Pulendran, Bali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795432/
https://www.ncbi.nlm.nih.gov/pubmed/35087093
http://dx.doi.org/10.1038/s41467-022-28197-9
_version_ 1784641069746487296
author Lee, Audrey
Scott, Madeleine K. D.
Wimmers, Florian
Arunachalam, Prabhu S.
Luo, Wei
Fox, Christopher B.
Tomai, Mark
Khatri, Purvesh
Pulendran, Bali
author_facet Lee, Audrey
Scott, Madeleine K. D.
Wimmers, Florian
Arunachalam, Prabhu S.
Luo, Wei
Fox, Christopher B.
Tomai, Mark
Khatri, Purvesh
Pulendran, Bali
author_sort Lee, Audrey
collection PubMed
description Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7/8 agonist, 3M-052, induces long-lived humoral immunity in non-human primates and is currently being evaluated in human clinical trials. However, the innate mechanisms of 3M-052 have not been fully characterized. Here, we perform flow cytometry, single cell RNA-seq and ATAC-seq to profile the kinetics, transcriptomics and epigenomics of innate immune cells in murine draining lymph nodes following 3M-052-Alum/Ovalbumin immunization. We find that 3M-052-Alum/OVA induces a robust antiviral and interferon gene program, similar to the yellow fever vaccine, which is known to confer long-lasting protection. Activation of myeloid cells in dLNs persists through day 28 and single cell analysis reveals putative TF-gene regulatory programs in distinct myeloid cells and heterogeneity of monocytes. This study provides a comprehensive characterization of the transcriptomics and epigenomics of innate populations in the dLNs after vaccination.
format Online
Article
Text
id pubmed-8795432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87954322022-02-07 A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice Lee, Audrey Scott, Madeleine K. D. Wimmers, Florian Arunachalam, Prabhu S. Luo, Wei Fox, Christopher B. Tomai, Mark Khatri, Purvesh Pulendran, Bali Nat Commun Article Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7/8 agonist, 3M-052, induces long-lived humoral immunity in non-human primates and is currently being evaluated in human clinical trials. However, the innate mechanisms of 3M-052 have not been fully characterized. Here, we perform flow cytometry, single cell RNA-seq and ATAC-seq to profile the kinetics, transcriptomics and epigenomics of innate immune cells in murine draining lymph nodes following 3M-052-Alum/Ovalbumin immunization. We find that 3M-052-Alum/OVA induces a robust antiviral and interferon gene program, similar to the yellow fever vaccine, which is known to confer long-lasting protection. Activation of myeloid cells in dLNs persists through day 28 and single cell analysis reveals putative TF-gene regulatory programs in distinct myeloid cells and heterogeneity of monocytes. This study provides a comprehensive characterization of the transcriptomics and epigenomics of innate populations in the dLNs after vaccination. Nature Publishing Group UK 2022-01-27 /pmc/articles/PMC8795432/ /pubmed/35087093 http://dx.doi.org/10.1038/s41467-022-28197-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lee, Audrey
Scott, Madeleine K. D.
Wimmers, Florian
Arunachalam, Prabhu S.
Luo, Wei
Fox, Christopher B.
Tomai, Mark
Khatri, Purvesh
Pulendran, Bali
A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
title A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
title_full A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
title_fullStr A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
title_full_unstemmed A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
title_short A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
title_sort molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795432/
https://www.ncbi.nlm.nih.gov/pubmed/35087093
http://dx.doi.org/10.1038/s41467-022-28197-9
work_keys_str_mv AT leeaudrey amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT scottmadeleinekd amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT wimmersflorian amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT arunachalamprabhus amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT luowei amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT foxchristopherb amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT tomaimark amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT khatripurvesh amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT pulendranbali amolecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT leeaudrey molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT scottmadeleinekd molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT wimmersflorian molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT arunachalamprabhus molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT luowei molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT foxchristopherb molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT tomaimark molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT khatripurvesh molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice
AT pulendranbali molecularatlasofinnateimmunitytoadjuvantedandliveattenuatedvaccinesinmice